Invention Grant
- Patent Title: IL-12 immunotherapy for cancer
- Patent Title (中): IL-12免疫治疗癌症
-
Application No.: US12598899Application Date: 2008-05-05
-
Publication No.: US08765462B2Publication Date: 2014-07-01
- Inventor: Jeffrey A. Medin , Christopher J. Paige
- Applicant: Jeffrey A. Medin , Christopher J. Paige
- Applicant Address: CA Toronto
- Assignee: University Health Network
- Current Assignee: University Health Network
- Current Assignee Address: CA Toronto
- Agency: Bereskin & Parr LLP
- Agent Carmela DeLuca; Noel Courage
- International Application: PCT/CA2008/000849 WO 20080505
- International Announcement: WO2008/134879 WO 20081113
- Main IPC: C12N15/63
- IPC: C12N15/63 ; C07H21/02 ; A61K48/00 ; C12N15/86 ; A61K38/20
Abstract:
Compositions and methods for delivering immune modulatory molecules to result in a therapeutic effect are disclosed. The compositions and methods use stably integrating lentiviral delivery systems. The methods are useful for therapeutically and prophylactically treating cancer such as leukemia.
Public/Granted literature
- US20100291043A1 IL-12 IMMUNOTHERAPY FOR CANCER Public/Granted day:2010-11-18
Information query
IPC分类:
